Clear cell carcinomas of the ovary and kidney: clarity through genomics
Citations Over TimeTop 11% of 2018 papers
Abstract
Clear cell ovarian carcinoma (CCOC) and clear cell renal cell carcinoma (ccRCC) both feature clear cytoplasm, owing to the accumulation of cytoplasmic glycogen. Genomic studies have demonstrated several mutational similarities between these two diseases, including frequent alterations in the chromatin remodelling SWI-SNF and cellular proliferation phosphoinositide 3-kinase-mammalian target of rapamycin pathways, as well as a shared hypoxia-like mRNA expression signature. Although many targeted treatment options have been approved for advanced-stage ccRCC, CCOC patients are still treated with conventional platinum and taxane chemotherapy, to which they are resistant. To determine the extent of similarity between these malignancies, we performed unsupervised clustering of mRNA expression data from these cancers. This review highlights the similarities and differences between these two clear cell carcinomas to facilitate knowledge translation within future research efforts. Copyright © 2018 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Related Papers
- → Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers(2008)454 cited
- → Clear cell adenocarcinoma of the ovary: A clinical analysis and comparison with serous carcinoma(1989)173 cited
- → Morphologic and Immunohistochemical Study of Clear Cell Carcinoma of the Uterine Endometrium and Cervix in Comparison to Ovarian Clear Cell Carcinoma(2017)55 cited
- → Utility of hepatocyte nuclear factor‐1β as a diagnostic marker in ovarian carcinomas with clear cells(2012)41 cited
- → Molecular portraits of clear cell ovarian and endometrial carcinoma with comparison to clear cell renal cell carcinoma(2019)